BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Laryngoscope, Rosiglitazone, rs4950928, DNMT1, T cell differentiation, HIV infection)
Bookmark Forward

QuickView for PEGASYS (compound)


Genetic Markers

Most Correlated Genes

  1. IFI44L
  2. RSAD2
  3. CCL8
  4. MX2
  5. SAA2
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN
  2. GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP
  3. GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN
  4. GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN
  5. GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Livers of chronic hepatitis C patients treated with PegIntron (pegIFNα-2b) or Pegasys (pegIFNα-2a)
  2. Liver biopsies of chronic hepatitis C patients treated with peg-IFNA-2a and ribavirin
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Characterization of the self-association of human interferon-α2b, albinterferon-α2b, and pegasys.
  2. Identification and Characterization of Resistance of Three Aphid Species on Contrasting Alfalfa Cult…
  3. High rates of HBsAg loss and seroconversion result from prolonged course of pegasys treatment].
  4. A Low-Cost Jamming Detection Approach Using Performance Metrics in Cluster-Based Wireless Sensor Net…
  5. Response and seroconversion rates among HBeAg-positive chronic HBV Egyptian patients treated with pe…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Continuing Treatment With Pegasys and Copegus
  2. Pegasys in Patients With Chronic Myeloid Leukemia (CML)
  3. A Study of Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic H…
  4. Trial of Pegasys® in Patients With Chronic Hepatitis C
  5. A Study of Setrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.